Delivering critical insights to help you capitalize on the current favourable investment climate for cell & gene therapies. Hone your business model to meet the requirements and expectations of both internal and key external stakeholders
Your year-round one-stop-shop to stay abreast of the key trends in cell & gene therapy bioprocessing. Specific areas of focus include quality/CMC and analytics, raw & starting materials and automation
Insight into the often complex and evolving regulation of cell and gene therapies from key geographic regions including USA, Canada, UK, Europe and Japan.
From troubleshooting cold chain logistics to overall supply chain data management and integration – everything you need to know about evolving practical and regulatory challenges and the technological state-of-the-art
The latest advances in the translational research and clinical development of cell and gene therapies.
A deep dive into specific bioprocess steps and enabling technologies – receive the blend of strategic insight and technical know-how needed to optimise viral and non-viral vector bioprocess R&D and scale-up.